Q4 2024 Earnings Call Transcript February 19, 2025 Outset Medical, Inc. beats earnings expectations. Reported EPS is $-0.37, ...

Welcome to the Outset Medical fourth-quarter 2024 earnings conference call. (Operator Instructions) Please be advised today's conference is being recorded. I would now like to hand the conference over ...

Outset Medical (Nasdaq: OM) shares got a boost today on fourth-quarter results that topped the consensus forecast on Wall ...

Outset Medical Inc (OM) reports sequential revenue growth, improved gross margins, and a strengthened balance sheet, despite challenges in console sales and manufacturing overhead.

RBC Capital analyst Shagun Singh Chadha maintained a Hold rating on Outset Medical (OM – Research Report) yesterday and set a price target of ...

In a report released today, Rick Wise from Stifel Nicolaus maintained a Buy rating on Outset Medical (OM – Research Report), with a price ...

Q4 2024 Management View CEO Leslie Trigg highlighted the company's progress in sequential revenue growth, gross margin improvement, and a decline in operating expenses. Revenue for the quarter reached ...

Divisional Commissioner Jammu Ramesh Kumar, who is also Chairman Shri Shiv Khori Shrine Board, today chaired a meeting to ...

New research shows almost 90% of people in England would agree to genetic testing to get the most effective medication and ...

The court found Budha guilty under Section 302 of the Indian Penal Code for stabbing Thakulla to death which inside a ...

Pharmacogenomics – an individual's genetic response to medications – is an increasingly important strand of personalised healthcare but little is known about the public's views on it.